Global Intravenous Solutions Market Insights, Forecast to 2025
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
The North America average price of intravenous solutions is in the increasing trend, from 404 USD/K Units in 2011 to 417 USD/K Units in 2016.
The classification of intravenous solutions includes crystalloids, colloids, and other. The proportion of crystalloids in 2016 is about 78%, and the proportion keeps steady.
Intravenous solutions are widely used for basic IV solutions, nutrient infusion solution. The most proportion of intravenous solutions is basic IV solutions, and the consumption in 2016 is 2627 M units.
USA is the largest consumption place, with a consumption market share nearly 81% in 2016. Following USA, Canada is the second largest consumption place with the consumption market share of 10%. Mexico consumption market share is about 7%.
The market is relatively concentrated. Baxter, Hospira, B. Braun Melsungen, Fresenius Kabi.are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Intravenous Solutions market is valued at 1710 million US$ in 2018 and will reach 1990 million US$ by the end of 2025, growing at a CAGR of 1.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravenous Solutions market based on company, product type, end user and key regions.
This report studies the global market size of Intravenous Solutions in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous Solutions in these regions.
This research report categorizes the global Intravenous Solutions market by top players/brands, region, type and end user. This report also studies the global Intravenous Solutions market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Baxter
Hospira
B. Braun Melsungen
Fresenius Kabi
Claris Lifesciences
Grifols
Vifor Pharma
JW Life Science
Market size by Product
Crystalloids
Colloids
Others
Market size by End User
Basic IV Solutions
Nutrient Infusion Solution
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Intravenous Solutions market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Intravenous Solutions market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intravenous Solutions companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Intravenous Solutions submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Intravenous Solutions are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravenous Solutions market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The North America average price of intravenous solutions is in the increasing trend, from 404 USD/K Units in 2011 to 417 USD/K Units in 2016.
The classification of intravenous solutions includes crystalloids, colloids, and other. The proportion of crystalloids in 2016 is about 78%, and the proportion keeps steady.
Intravenous solutions are widely used for basic IV solutions, nutrient infusion solution. The most proportion of intravenous solutions is basic IV solutions, and the consumption in 2016 is 2627 M units.
USA is the largest consumption place, with a consumption market share nearly 81% in 2016. Following USA, Canada is the second largest consumption place with the consumption market share of 10%. Mexico consumption market share is about 7%.
The market is relatively concentrated. Baxter, Hospira, B. Braun Melsungen, Fresenius Kabi.are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Intravenous Solutions market is valued at 1710 million US$ in 2018 and will reach 1990 million US$ by the end of 2025, growing at a CAGR of 1.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravenous Solutions market based on company, product type, end user and key regions.
This report studies the global market size of Intravenous Solutions in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous Solutions in these regions.
This research report categorizes the global Intravenous Solutions market by top players/brands, region, type and end user. This report also studies the global Intravenous Solutions market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Baxter
Hospira
B. Braun Melsungen
Fresenius Kabi
Claris Lifesciences
Grifols
Vifor Pharma
JW Life Science
Market size by Product
Crystalloids
Colloids
Others
Market size by End User
Basic IV Solutions
Nutrient Infusion Solution
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Intravenous Solutions market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Intravenous Solutions market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intravenous Solutions companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Intravenous Solutions submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Intravenous Solutions are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravenous Solutions market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
